Literatur

• Literatur

• 1 Becker S, Rapps N, Zipfel S. Psychotherapy in obesity – a systematic review. Psychother Psychosom Med Psychol 2007; 57 (11) 420-427.
• 2 Berg jr A, Frey I, Hamm M. et al. Das M.O.B.I.L.I.S.-Programm. Adipositas 2008; 02 (02) 90-95.
• 3 Brown SA, Upchurch S, Anding R. et al. Promoting weight loss in type II diabetes. Diabetes Care 1996; 19 (06) 613-624.
• 4 Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health Obes Res. 1998; 06 (Suppl. 02) 51-209.
• 5 Deutsche Gesellschaft für Ernährung. Maßnahmen zur Gewichtsreduktion bei Erwachsenen. DGE-Beratungsstandards. 1998
• 6 Douketis JD, Macie C, Thabane L, Williamson DF. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes 2005; 29 (10) 1153-1167.
• 7 Ellert U, Lampert T, Ravens-Sieberer U. Measuring health-related quality of life with the SF-8. Normal sample of the German population. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2005; 48 (12) 1330-1337.
• 8 European Association for the Study of Obesity. Guidelines for the management of obesity in adults. European Project for Primary Care. 2002
• 9 Franz MJ, VanWormer JJ, Crain AL. et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107 (10) 1755-1767.
• 10 Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007; 132 (06) 2208-2225.
• 11 Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992; 16 (06) 397-415.
• 12 Hauner H, Buchholz G, Hamann A. et al. Evidenzbasierte Leitlinie: Prävention und Therapie der Adipositas. 2007
• 13 Hauner H, Wechsler JG, Kluthe R. et al. Qualitätskriterien für ambulante Adipositasprogramme. Akt Ernaehr Med 2000; 25 (163) 165.
• 14 Huang Z, Hankinson SE, Colditz GA. et al. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997; 278 (17) 1407-1411.
• 15 James PT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11 (01) 3-8.
• 16 Jeffery RW, Drewnowski A, Epstein LH. et al. Long-term weght maintenance of weight loss: current status. Health Psychol 2000; 19 (01) 5-16.
• 17 Katz DL, O’Connell M, Yeh MC. et al. Public health strategies for preventing and controlling overweight and obesity in school and worksite settings: a report on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 2005; 54 (RR-10|): 1-12.
• 18 Klose G. Fettstoffwechselstörungen bei Adipositas. Adipositas 2009; 03: 128-132.
• 19 Knowler WC, Barrett-Connor E, Fowler SE. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346 (06) 393-403.
• 20 Koh-Banerjee P, Wang Y, Hu FB. et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 2004; 159 (12) 1150-1159.
• 21 MacMahon S, MacDonald G. Treatment of high blood pressure in overweight patients. Nephron 1987; 47 (01) 8-12.
• 22 Scholz GH. Evaluation des DGE-Selbsthilfeprogramms „ICH nehme ab”. Gewichtsverlust, Ernährungsmuster und Akzeptanz nach einjähriger beratergestützter Intervention bei übergewichtigen Personen. Aktuel Ernahrungsmed 2005; 52: 226-231.
• 23 Stevens VJ, Obarzanek E, Cook NR. et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134 (01) 1-11.
• 24 Stoschitzky K. Nichtmedikamentöse Therapie der Hypertonie – Life-Style-Modifikation. J Hyperton 2004; 08: 20-22.
• 25 Turner-Bowker DM, Bayliss MS, Ware Jr JE, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res 2003; 12 (08) 1003-1012.
• 26 Ueno T, Sugawara H, Sujaku K. et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27 (01) 103-107.
• 27 van Dam RM, Willett WC, Manson JE, Hu FB. The relationship between overweight in adolescence and premature death in women. Ann Intern Med 2006; 145 (02) 91-97.
• 28 Ware J, Kosinski M. et al. How to score and interpret single-item health status measures: a manual for users of the SF-8 health survey. Lincoln: QualityMetric Incorporated; 2001
• 29 Weigensberg MJ, Lane CJ, Winners O. et al. Acute Effects of Stress-Reduction Interactive Guided Imagery on Salivary Cortisol in Overweight Latino Adolescents. J Altern Complement Med 2009; 15 (03) 297-303.
• 30 Weisbrod B. Evaluation eines langfristigen, interdisziplinären Programms zur Gewichtsreduktion bei Adipositas (ADIPOSITIV). Dissertation. Universität Würzburg, Medizinische Fakultät. 2003
• 31 Westenhöfer J. So hilft Verhaltenstherapie beim Abnehmen. MMW-Fortschr Med 2001; 143: 878-880.
• 32 WHO. Obesity: preventing and managing the global epidemic. WHO Technical report Series. 894. Genf: 2000
• 33 Williamson DF, Pamuk E, Thun M. et al. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40–64 years. Am J Epidemiol 1995; 141 (12) 1128-1141.
• 34 Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23 (10) 1499-1504.
• 35 Wiltink J, Weber MM, Beutel ME. Mental co-morbidity, health care utilization and illness behaviour in overweight and obese subjects--results from a representative German community survey. Psychother Psychosom Med Psychol 2007; 57 (11) 428-434.